Report
Matthew Young
EUR 850.00 For Business Accounts Only

Morningstar | SRCL Updated Forecasts and Estimates from 28 Jun 2019

Stericycle is by far the largest domestic provider of regulated medical waste management and ancillary compliance services, and among the largest in its international geographies. In its flagship domestic med-waste operations, Stericycle built its unmatched processing capabilities and network density through hundreds of tuck-in acquisitions (mostly accretive) over the past decade. The firm has also embarked on a few large deals including the 2014 PSC Environmental acquisition (industrial hazardous waste) and the 2015 Shred-it acquisition, which added secure document shredding services.Stericycle had enjoyed a long history of high-single-digit organic growth and healthy profitability, but by late 2015 it saw the emergence of headwinds that have plagued operating performance and execution. PSC and Shred-it were large transactions that required costly integration efforts, while making the firm a more complex organization. Shred-it added ancillary services to the mix, but both deals initially weighed on margins and ROICs. Additionally, the firm is amid a painful pricing-reset period among small-quantity, or SQ, med-waste accounts. The consolidation of independent healthcare practices into larger hospital groups over the past decade has boosted these customers’ bargaining power, and these blended accounts are now pushing back heavily on price as they grapple with their own budget constraints and regulatory headwinds. Furthermore, visibility surrounding the class action SQ-customer lawsuit (settled last year) sparked pricing concession among independent healthcare practice accounts as well. That said, we don’t think Stericycle is in a perpetual state of decline and, in our view, the firm isn't losing its footing against its small regional peers. For one, its core med-waste network enjoys sustainable competitive advantages rooted in route density. We also expect the bulk of SQ-account pricing concessions to work in by the end of 2019. Moreover, although management’s multiyear turnaround program (including a major ERP updgrade) will hit profitability in the years ahead, it should result in better internal controls, higher visibility, and improved execution.
Underlying
Stericycle Inc.

Stericycle is engaged in the medical and hazardous waste management and secure information services. The company's segments are: North America, and International Regulated Waste and Compliance Services, which provides medical waste management services, pharmaceutical waste services, compliance programs, retail and healthcare, industrial and manufacturing hazardous waste management and secure information destruction; and Domestic Communication and Related Services, which provides appointment reminders, secure messaging, event registration, and other communications mainly for hospitals and integrated delivery network's as well as regulated recall and returns management communication, and logistics.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Matthew Young

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch